Doctors Note Logo

Published on: 9/12/2026

Is abnormal MCHC on a blood test a sign of cancer or a serious disease?

An abnormal MCHC (mean corpuscular hemoglobin concentration) on a complete blood count is usually not a sign of cancer, and on its own it rarely points to a serious disease. Low MCHC most often reflects iron deficiency, chronic blood loss, or an inherited condition like thalassemia, while high MCHC is frequently caused by hemolytic anemias, hereditary spherocytosis, or even a lab artifact such as clumped cells or lipemic blood. In uncommon cases, a persistently abnormal MCHC alongside other flagged results (low white cells, low platelets, or unexplained anemia) can prompt further testing for bone marrow or blood disorders. Several factors influence what your result means, including your other CBC values, your symptoms, and your medical history, so see below to understand more before drawing conclusions.

Because one number out of range means very little without context, the fastest way to know whether your result deserves urgent attention or routine follow-up is to evaluate it alongside your symptoms; take a free, instant, online symptom check to see which conditions match your situation and what next steps make sense with your doctor.

Last reviewed for medical accuracy: 09/11/2026

answer background

Explanation

What is MCHC in a blood test?

MCHC stands for Mean Corpuscular Hemoglobin Concentration. It’s a measure of how much hemoglobin your red blood cells carry, expressed as grams per deciliter (g/dL). Hemoglobin is the protein that transports oxygen from your lungs to the rest of your body. By looking at MCHC, doctors can get clues about the type of anemia you might have or other red blood cell disorders.

  • Normal MCHC range: ~33–36 g/dL
  • Low MCHC: red cells have less hemoglobin than normal (hypochromia)
  • High MCHC: red cells appear overly concentrated with hemoglobin (hyperchromia)

Common causes of low MCHC (hypochromia)

When MCHC falls below the normal range, red blood cells look paler under the microscope. This finding often points to:

Iron-deficiency anemia
– Most common cause of anemia worldwide
– May result from blood loss (menstruation, ulcers), poor diet, or absorption issues

Thalassemia trait
– Genetic disorder affecting hemoglobin production
– Often mild, may run in families

Chronic disease anemia
– Long-term conditions (e.g., rheumatoid arthritis, chronic infections) can affect iron use

Lead poisoning
– Rare in adults but still seen in some occupations or environmental exposures

Common causes of high MCHC (hyperchromia)

A raised MCHC is less frequent than a low reading. Possible reasons include:

Hereditary spherocytosis
– Genetic condition where red cells are misshapen (spherocytes) and lose flexibility
– Can cause mild to moderate hemolytic anemia

Autoimmune hemolytic anemia
– Body’s immune system attacks its own red blood cells
– Cells may lose water and shrink, concentrating hemoglobin

Laboratory artifact
– Lipemia (high blood fats) or cold agglutinins can falsely elevate MCHC
– Repeat testing or special handling may be needed

Is an abnormal MCHC a sign of cancer or serious disease?

An isolated abnormal MCHC rarely points directly to cancer. Instead, it helps classify the type of anemia or red cell disorder. However, certain blood cancers (like some leukemias) and bone marrow diseases can cause or worsen anemia, altering MCHC in the broader context of other tests.

Key considerations:

• Look at the whole CBC
– Hemoglobin, hematocrit, MCV (average cell size), RDW (size variation) and platelet count
– A pattern of abnormalities may raise concern for bone marrow involvement

• Check additional tests
– Iron studies (ferritin, TIBC), vitamin B12/folate levels
– Reticulocyte count (young red cells) to gauge bone marrow response

• Review symptoms and risk factors
– Fatigue, weight loss, night sweats or persistent fevers can signal more serious issues
– Personal/family history of blood disorders or cancer

On its own, a mildly low or high MCHC usually reflects a common form of anemia. It’s uncommon for a slight MCHC change—without other abnormalities—to be the first clue to cancer or another life-threatening disease.

When to seek further evaluation

Consider talking to your doctor if you have:

  • Persistent fatigue, weakness or shortness of breath
  • Unexplained bruising or bleeding
  • Significant weight loss or night sweats
  • A family history of blood disorders or cancer
  • Repeated abnormal CBC tests

Your healthcare provider may recommend:

  • Detailed iron studies, vitamin levels, or hemoglobin electrophoresis
  • A repeated CBC to rule out lab error
  • Referral to a hematologist for specialized testing

Next steps you can take today

If you’re concerned about your test results or new symptoms, starting with some self-guided information can help you prepare for your doctor’s visit.

Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to explore possible causes and get guidance on when to seek care.

Speak to a doctor

Abnormal blood test results can be unsettling, but they serve as clues pointing toward the right diagnosis. If your MCHC or any other lab value is outside the normal range, it’s important to:

  1. Discuss results with your primary care physician or a hematologist
  2. Follow up promptly on recommended tests or referrals
  3. Report any new or worsening symptoms immediately

Only a qualified healthcare professional can interpret your full clinical picture and recommend appropriate treatment. If you’re ever in doubt—especially if symptoms could be life-threatening—seek medical attention right away.

(References)

  • * Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86-105. doi: 10.3109/10408363.2014.992064. Epub 2014 Dec 23. PMID: 25535770.

  • * Song Y, Huang Z, Kang Y, Lin Z, Lu P, Lin Q, Cai Z, Cao Y, Zhu X. Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer. Biomed Res Int. 2018;2018:9858943. doi: 10.1155/2018/9858943. Epub 2018 Dec 13. PMID: 30643826; PMCID: PMC6311266.

  • * Shota S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y. Prognostic Significance of Pre- and Post-operative Red-Cell Distribution Width in Patients with Gastric Cancer. J Gastrointest Surg. 2020 May;24(5):1010-1017. doi: 10.1007/s11605-019-04392-w. Epub 2019 Sep 16. PMID: 31529200.

  • * Vidili G, Zinellu A, Mangoni AA, Arru M, De Murtas V, Cuccuru E, Fancellu A, Paliogiannis P. Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma. Medicina (Kaunas). 2024 Feb 25;60(3). doi: 10.3390/medicina60030391. Epub 2024 Feb 25. PMID: 38541117; PMCID: PMC10972095.

  • * Wang P, Zhang Y, Xu W, Zheng Y, Jia L, He J, He M, Chen L, Hao P, Xiao Y, Peng L, Chong W, Hai Y, You C, Fang F. Association between elevated preoperative red cell distribution width and mortality after brain tumor craniotomy. Neurosurg Rev. 2024 May 28;47(1):237. doi: 10.1007/s10143-024-02462-5. Epub 2024 May 28. PMID: 38802619.

  • * Liu X, Wu H, Zhang S, Zhu Z, Liu C, Cao J. Higher red cell distribution width (RDW) is associated with increased all-cause and cardiovascular mortality in patients with breast cancer: A retrospective analysis of NHANES data (1999-2018). PLoS One. 2025;20(7):e0328680. doi: 10.1371/journal.pone.0328680. Epub 2025 Jul 28. PMID: 40720508; PMCID: PMC12303287.

  • * Salzbrunn JB, van Zeventer IA, de Graaf AO, Klatte S, van Pelt LJ, Kamphuis P, van Bergen MGJM, Dinmohamed AG, van der Reijden BA, Linssen J, Schuringa JJ, Jansen JH, Huls G. Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets. Br J Haematol. 2025 Sep;207(3):1085-1095. doi: 10.1111/bjh.70031. Epub 2025 Aug 3. PMID: 40754673; PMCID: PMC12436208.

  • * Kefeli A, Onayrılı F, Gokcal F. The importance of blood parameters in the detection of intestinal metaplasia and early diagnosis of gastric cancer. Afr Health Sci. 2024 Sep;24(3):205-215. doi: 10.4314/ahs.v24i3.25. PMID: 40777975; PMCID: PMC12327099.

  • * Yang X, Pan Y, Zhao P, Chen N, Ma Y, Bao Y, Qi L, Du X. Prognostic value of red cell distribution width-to-albumin ratio in septic patients with malignancies: A retrospective cohort study based on the MIMIC-IV database. Sci Prog. 2025 Jul-Sep;108(3):368504251370990. doi: 10.1177/00368504251370990. Epub 2025 Aug 19. PMID: 40827332; PMCID: PMC12365464.

  • * Gao H, Gao F, Ma Y, Mao Y, Liu K. Association between RDW and in-hospital mortality among multiple myeloma patients: a retrospective investigation of the MIMIC-IV database. Hematology. 2025 Dec;30(1):2569906. doi: 10.1080/16078454.2025.2569906. Epub 2025 Oct 10. PMID: 41071093.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.